Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) CFO Sells $234,640.00 in Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 4,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 1st. The stock was sold at an average price of $58.66, for a total transaction of $234,640.00. Following the sale, the chief financial officer now directly owns 93,338 shares of […]

Related Keywords

Timothy Eugene Sullivan ,Apellis Pharmaceuticals ,Needham Company ,First Horizon Advisors Inc ,Citigroup ,Apellis Pharmaceuticals Inc ,Apellis Pharmaceuticals Trading Down ,News Ratings For Apellis Pharmaceuticals Daily ,Advisor Group Holdings Inc ,Quarter For Apellis Pharmaceuticals ,Cim Investment Management Inc ,Nasdaq ,Wells Fargo Company ,Hedge Funds Weigh In On Apellis Pharmaceuticals ,Get Free Report ,Eugene Sullivan ,Pharmaceuticals Trading Down ,Investment Management ,Capital Advisors ,Group Holdings ,North Carolina ,First Horizon Advisors ,Horizon Advisors ,Wells Fargo ,Apellis Pharmaceuticals Daily ,Nasdaq Apls ,Apls ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,